The receptor for HIV: Dissection of CD4 and studies on putative accessory factors

Current Topics in Microbiology and Immunology

Volumn 205, Issue , 1996, Pages 136-158

  James, W ^a   Weiss, R A ^b   Simon, J H M ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENT RECEPTOR; DEXTRAN SULFATE; FC RECEPTOR; GLYCOLIPID; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN IDIOTYPE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BINDING SITE; HETEROKARYON; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029655669     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (152)

1. Allan J, Strauss J, Buck D (1990) Enhancement of SIV infection with soluble receptor molecules. Science 247. 1084-1088
2. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, Axel R, Truneh A, et al (1989) Identification of the residues in human CD4 critical for the binding of HIV Cell 57 469-481
3. Ashkenazi A, Presta LG, Marsters SA, Camerato TR, Rosenthal KA, Fendly BM, Capon DJ (1990) Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci USA 87: 7150-7154
4. Autiero M, Abrescia P, Dettin M, Di BC, Guardiola J (1991) Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein. Virology 185 820-828
5. Avril LE, Di MM, Barin F, Gauthier F (1993) Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein. FEBS Lett 317: 167-172
6. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J, De CE (1988a) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85. 6132-6136
7. Baba M, Snoeck R, Pauwels R, De CE (1988b) Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses including herpes simplex virus cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother 32. 1742-1745
8. Batinic D, Robey FA (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem 267: 6664-6671
9. Beddows S, Bieniasz P, Shaunak S, Weber J (1993) HIV replication in CD4-negative cell lines: Effect of cloning, CD4 expression and inhibitory by dextrin sulphate. Antiviral Chem Chemother 4. 173-177
10. Berger EA, Lifson JD, Eiden LE (1991) Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci USA 88: 8082-8086
11. Bhat S, Mettus RV, Reddy EP, Ugen KE, Srikanthan V, Williams WV, Weiner DB (1993) The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retroviruses 9: 175-181
12. 2-terminal domains. Science 260: 976-983
13. Broder CC, Berger EA (1993) CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J Virol 67 913-926
14. Broder CC, Dimitrov DS, Blumenthal R, Berger EA (1993) The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 be overcome by a human cell component(s). Virology 193 483-491
15. Broder CC, Nussbaum O, Gutheil WG, Bachovchin WW, Berger EA, Patience C, McKnight A, Clapham PR, Boyd MT, Weiss RA, Schulz TF, Camerini D et al (1994) CD26 antigen and HIV fusion? Science 264. 1156-1165
16. Brodsky MH, Warton M, Myers RM, Littman DR (1990) Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 144: 3078-3086
17. Burkly LC, Olson D, Shapiro R, Winkler G, Rosa JJ, Thomas DW, Williams C, Chisholm P (1992) Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol 149: 1779-1787
18. Callahan LN, Phelan M, Mallinson M, Norcross MA (1991) Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions J Virol 65: 1543-1550
19. + cells. Science 262: 2045-2050
20. Camerini D, Seed B (1990) A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 60: 747-754
21. Cereda PM, Palu G, Rassu M, Toni M, Malwood W, Dettin M, Di BC (1991) Anti-HIV-1 activity of CD4 synthetic oligopeptides representative of the putative gp120 binding site Antiviral Chem Chemother 2. 157-161
22. Chen YH, Bock G, Vornhagen R, Steindl F, Katinger H, Dierich MP (1993) HIV-1 gp41 binds to several proteins on the human B-cell line. Raji Mol Immunol 30: 1159-1163
23. Cheng-Mayer C (1990) Biological and molecular features of HIV-1 related to tissue tropism. AIDS 4: S49-S56
24. Chesebro B, Buller R, Portis J, Wehrly K (1990) Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol 64 215-221
25. Choe HR, Sodroski J (1992) Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding J Acquit Immune Defic Syndr 5: 204-210
26. Christofinis G, Papadaki L, Sattentau Q, Ferns RB, Tedder R (1987) HIV replicates in cultured human brain cells AIDS 1: 229-234
27. Clapham P (1991) Human immunodeficiency virus infection of non-haematopoietic cells. The role of CD4-independent entry Rev Med Virol 1 51-58
28. Clapham P, McKnight A, Weiss R (1992) Human immunodeficiency virus Type2 infection and fusion of CD4-negative cell lines: induction and enhancement by soluble CD4. J Virol 66: 3531-3537
29. Clapham PR, Blanc D, Weiss RA (1991) Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology 181: 703-15
30. Clayton LK, Hussey RE, Steinbrich R, Ramachandran H, Husain Y, Reinherz EL (1988) Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding Nature 335. 363-366
31. Collin M, Illei P, James W, Gordon S (1994) Definition of the range and distribution of HIV macrophage tropism using PCR-based infectivity measurements J Gen Virol 75: 1597-1603
32. Cook DG, Fantini J, Spitalnik SL, Gonzalez-Scarano F (1994) Binding of human immunodeficiency virus type 1 (HIV-1) Gp120 to galactosylceramide (GalCer): relationship to the V3 Loop Virology 201: 206-214
33. Cordonnier A, Montagnier L, Emerman M (1989) Single amino-acid changes in HIV envelope affect viral tropism and receptor binding Nature 340 571-574
34. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 312: 763-767
35. Dalgleish AG, Chanh TC, Thomson BJ, Malkovsky M, Kennedy RC (1987) Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine Lancet 2 1047-1049
36. Davis SJ, Schockmel GA, Somoza C, Buck DW, Healey DG, Rieber EP, Reiter C, Williams AF (1992) Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors Nature 358: 76-79
37. Dragic T, Alizon M (1993) Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2. J Virol 67. 2355-2359
38. Dragic T, Charneau P, Clavel F, Ahzon M (1992) Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol 66. 4794-4802
39. Dragic T, Picard L, Alizon M (1995) Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins J Virol 69: 1013-1018
40. Eiden LE, Lifson JD (1992) HIV interactions with CD4 . a continuum of conformations and consequences. Immunol Today 13: 201-206
41. Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, Flavell RA (1988) HIV infection is blocked in vitro by recombinant soluble CD4 Nature 331: 76-78
42. Fu YK, Hart TK, Jonak ZL, Bugelski PJ, (1993) Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120 J Virol 67. 3818-3825
43. Golding H, Blumenthal R, Manischewitz J, Littman DR, Dimitrov DS (1993) Cell fusion mediated by interaction of a hybrid CD4 CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time J Virol 67: 6469-6475
44. Gomatos PJ, Stomatos NM, Gendelman HE, Fowler A, Hoover DL, Kalter DC, Burke DS, Tramont EC, Meltzer MS (1990) Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells J Immunol 144: 4183-4188
45. Goudsmit J, Smit L (1990) CD 11a/CD18 (LFA-1) epitopes involved in syncytium formation among CD4+T-cells following cell free HIV-1 infection Viral Immunol 3 289-293
46. Gruber MF, Webb D, Gerrard TL, Mostowski HS, Vujcic L, Golding H (1991) Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line AIDS Res Hum Retroviruses 7 45-53
47. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silbergerg DH, GonzalezScarano F (1991) Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide Science 253 320-323
48. Harrington RD, Geballe AP (1993) Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line J Virol 67 5939-5947
49. Harrop HA, Coombe DR, Rider CC (1994) Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding AIDS 8: 183-192
50. Hasunuma T, Tsubota H, Watanabe M, Chen ZW, Lord CI, Burkly LC, Daley JF, Letvin NL (1992) Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes J Immunol 148: 1841-1846
51. Healey D, Dianda L, Moore JP, McDougal JS, Moore MJ, Estess P, Buck D, Kwong PD, Beverley P, Sattentau QJ (1990) Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding J Exp Med 172: 1233-1242
52. Healey DG, Dianda L, Buck D, Schroeder K, Truneh A, Sattentau QJ, Beverley P (1991) A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization. Eur J Immunol 21 1491-1498
53. Hildreth J, Orentas RJ (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation Science 244 1075-1078
54. Hosoya M, Balzarini J, Shigeta S, De CE (1991) Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins Antimicrob Agents Chemother 35: 2515-2520
55. Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, Siliciano RF, Dorfman T, Walker B, Sodroski J, Reinherz EL (1988) A soluble CD4 protein selectively inhibits HIV replication and syncytium formation Nature 331. 78-81
56. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253: 71-73
57. Ito M, Baba M, Sato A, Pauwels R, De CE, Shigeta S (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro Antiviral Res 7 367-367
58. Jameson BA , Rao PE, Kong LI, Hahn BH, Shaw GM, Hood LE, Kent S (1988) Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein Science 240 1335-1339
59. Joualt T, Chapuis F, Bahraoui E, Gluckman JC (1991) Infection of monocytic cells by HIV 1: Combined role of FcR and CD4 Res Virol 142: 183-188
60. Jouault T, Chapuis F, Olivier R, Parravicini C, Bahraoui E, Gluckman JC (1989) HIV infection of monocytic cells: role of antibody-mediated virus binding to Fc-gamma receptors. AIDS 3: 125-133
61. June RA, Schade SZ, Bankowski MJ, Kuhns M, McNamara A, Lint TF, Landay AL, Spear GT (1991) Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS 5: 269-274
62. Kalyanaraman VS, Rausch DM, Osborne J, Padgett M, Hwang KM, Lifson JD, Eiden LE (1990) Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation. J Immunol 145 4072-4078
63. Kido H, Fukutomi A, Katunuma N (1991) A novel membrane-bound serine esterase in human T4+-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1. Biomed Biochim Acta 50. 781-789
64. Klatzmann D, Barre SF, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun VF, Rouzieux C, Gluckman JC, Chermann JC et al (1984a) Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225. 59-63
65. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L (1984b) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature 312: 767-768
66. Langedijk J, Puijk WC, Van HW, Meloen RH (1993) Location of CD4 dimenzation site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC J Biol Chem 268. 16875-16878
67. Lasarte JJ, Sarobe P, Golvano J, Prieto I, Civeira MP, Gullon A, Sarin PS, Prieto J, BorrasCuesta F (1994) CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro. J Acquir Immune Defic Syndr 7 129-134
68. Layne SP, Merges MJ, Dembo M, Spouge JL, Nara PL (1990) HIV requires multiple gp120 molecules for CD4-mediated infection Nature 346 277-279
69. Lederman S, Gulick R, Chess L (1989) Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV J Immunol 143: 1149-1154
70. Leonard C, Spellman N, Riddles L, Harris R, Thomas J, Gregory T (1990) Assignment of intrachain disulphide bonds and characterization of potential glycosylation sites of type 1 human immunodeficiency virus envelope glycoprotein expressed in chinese hamster ovary cells J Biol Chem 265 10373-10376
71. Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE (1988) Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity Science 241: 712-716
72. Lifson JD, Rausch DM, Kalyanaraman VS, Hwang KM, Eiden LE (1991) Synthetic peptides allow discrimination of structural features of CD4 (81-92) important for HIV-1 infection versus HIV-1-induced syncytium formatton AIDS Res Human Retroviruses 7: 521-527
73. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain Cell 47: 333-348
74. Malvoisin E, Wild F (1994) Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor. J Gen Virol 75: 839-847
75. Mann DL, Read Connole E, Arthur LO, Robey WG, Wernet P, Schneider EM, Blattner WA, Popovic M (1988) HLA-DR is involved in the HIV-1v binding site on cells expressing MHC class II antigens. J Immunol 141: 1131-1136
76. Mbemba E, Chams V, Gluckman JC, Klatzmann D, Gattegno L (1992a) Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate. Biochim Biophys Acta 1138: 62-67
77. Mbemba E, Czyrski JA, Gattegno L (1992b) The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein. Biochim Biophys Acta 1180. 123-129
78. McAlarney T, Apostolski S, Lederman S, Latov N (1994) Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids J Neurosci Res 37 453-460
79. McClure MO, Moore JP, Blanc DF, Scotting P, Cook G, Keynes RJ, Weber JN, Davies D, Weiss RA (1992) investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses 8: 19-26
80. McDougal JS, Nicholson J, Cross GD et al. (1986) Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule conformation dependence epitope mapping, antibody inhibition, and potential for idiotypic mimicry J Immunol 137. 2937-2944
81. McKeating JA, Griffiths PD, Weiss RA (1990) HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor Nature 343 659-661
82. McKeating J, Balfe P, Clapham P, Weiss RA (1991a) Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity J Virol 65 477-4785
83. McKeating JA, McKnight A, Moore JP (1991b) Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates, effects on infectivity and neutralization J Virol 65 852-86O
84. McKeating JA, Cordell J, Dean CJ, Balfe P (1992) Synergisttc interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120 Virology 191. 732-742
85. McKnight A, Clapham PR, Weiss RA (1994) HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages Virology 201: 8-18
86. Meshcheryakova D, Andreev S, Tarasova S, Sidorova M, Vafina M, Kornilaeva G, Karamov E, Khaitov R (1993) CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments. Mol Immunol 30 993-1001
87. Mitsuya H, Looney DJ, Kuno S, Ueno R, WongStaal F, Broder S (1988) Dextran sulfate suppression of viruses in the HIV family. inhibition of virion binding to CD4+ cells.Science 240: 646-649
88. Mizrachi Y, Zeira M, Shahabuddin M, Li G, Sinangil F, Volsky DJ (1991) Efficient binding, fusion and entry of HIV1 into CD4-negative neural cells: a mechanism for neuropathogenesis in AIDS. Bull Inst Pasteur 89 81-96
89. Mizukami T, Fuerst TR, Berger EA, Moss B (1988) Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci USA 85: 9273-9277
90. Moebius U, Clayton LK, Abraham S, Harrison SC, Reinherz EL (1992) The human immunodeficiency virus gp120 binding site on CD4. delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure J Exp Med 176: 507-517
91. Montefiori DC, Zhou J, Shaff DI (1992) CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody Clin Exp Immunol 90. 383-389
92. Moore JP (1993) A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1 J Virol 67 3656-3659
93. Moore JP, McKeating JA, Weiss RA, Sattentau QJ (1990) Dissociation of gp120 from HIV-1 virions induced by soluble CD4 Science 250 1139-1142
94. Moore JP, McKeating JA, Norton WA, Sattentau QJ (1991) Direct measurement of soluble CD-4 binding to human immunodeficiency virus type 1 virions gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4 Journal of Virology 65: 1133-1140
95. Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD (1992a) Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol 66 235-243
96. Moore JP, Sattentau QJ, Klasse PJ, Burkly LC (1992b) A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells. J Virol 66: 4784-4793
97. Moore JP, Burkly LC, Connor RI, Cao Y, Tizard R, Ho DD, Fisher RA (1993) Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4 AIDS Res Hum Retroviruses 9: 529-539
98. Moore JP, Sattentau QJ, Wyatt R, Sodroski J (1994) Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68: 469-484
99. Nara PL, Hwang KM, Rausch DM, Lifson JD, Eiden LE (1989) CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle. Proc Natl Acad Sci USA 86 7139-7143
100. Nygren A, Bergman T, Matthews T, Jornvall H, Wigzell H (1988) 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein bind to the CD4 receptor. Proc Natl Acad Sci USA 85: 6543-6546
101. Ohki K, Kimura T, Jones IM, Morita F, Ikuta K (1994) Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions. Vaccine 12: 343-350
102. Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J (1990) Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 binding. J Virol 64: 5701-5707
103. Orloff SL, Kennedy MS, Belperron AA, Maddon PJ, McDougal JS (1993) Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4, J Virol 67: 1461-1471
104. Owens RJ, Tanner CC, Mulligan MJ, Srinivas RV, Compans RW (1990) Oligopeptide inhibitors of HIV-induced syncytium formation. AIDS Res Hum Retroviruses 6: 1289-1296
105. Pal R, Nair BC, Hoke GM, Sarngadharan MG, Edidin M (1991) Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1) J cell Physiol 147 326-332
106. Parish CR, Low L, Warren HS, Cunningham AL (1990) A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region J Immunol 145: 1188-1195
107. Patel M, Yanagishita M, Roderiquez G, Bou HD, Oravecz T, Hascall VC, Norcross MA (1993) Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines AIDS Res Hum Retroviruses 9 167-174
108. Pollard S, Rosa M, Rosa J, Wiley D (1992) Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region EMBO J 11. 585-591
109. Potts BJ, Field KG, Wu Y, Posner M, Cavacini L, WhiteScharf M (1993) Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3-directed monoclonal antibodies Virology 197: 415-419
110. Poulin L, Evans LA, Tang SB, Barboza A, Legg H, Littman DR, Levy JA (1991) Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol 65: 4893-4901
111. Rausch DM, Hwang KM, Padgett M, Voltz AH, Rivas A, Engleman E, Gaston I, McGrath M, Fraser B, Kalyanaraman VS, Nara PL, Dunlop N et al. (1990) Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virusinduced cell fusion, and postinfection viral transmission in virtro implications for the design of small-peptide anti-HIV therapeutic agents Ann N Y Acad Sci 616. 125-148
112. Rausch DM, Lifson JD, Padgett MP, Chandrasekhar B, Lendvay J, Hwang KM, Eiden LE (1992) CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitro Biochem Pharmacol 43 1785-1796
113. Reisinger EC, Vogetseder W, Berzow D, Kofler D, Bitterlich G, Lehr HA, Wachter H, Dierich MP (1990) Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937 AIDS 4: 961-965
114. Repke H, Gabuzda D, Palu G, Emmrich F, Sodroski J (1992) Effects CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol 149. 1809-1816
115. 2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. Proc Natl Acad Sci USA 85 6102-6106
116. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai X, Xuong N, Axel R, Sweet RW, Hendrickson WA (1990) Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348 419-426
117. Sato Al, Balamuth FB, Ugen KE, Williams WV, Weiner DB (1994) Identification of CD7 glycoprotein as an accessory molecule in HIV-1- mediated syncytium formation and cellfree infection. J Immunol 152. 5142-5152
118. Sattentau QJ, Dalgleish AG, Weiss RA, Beverley P (1986) Epitopes of the CD4 antigen and HIV infection Science 234 1120-1123
119. Sattentau QJ, Clapham PR, Weiss RA, Beverley P, Montagnier L, Alhalabi MF, Gluckmann JC, Klatzmann D (1988) The human and simian immunodeficiency viruses HIV-1, HIV-2, and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule AIDS 2 101-105
120. Sattentau QJ, Moore JP, Vignaux F, Traincard F, Poignard P (1993) Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding J Virol 67: 7383-7393
121. Schmitt D, DezutterDambuyant C, Hanau D, Kolbe H, Kieny MP, Cazenave JP, Thivolet J (1990) In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-GP120-binding site Res Virol 141: 209-215
122. Schockmel G, Somoza C, Davis S, Williams A, Healey D (1992) Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4. J Exp Med 175. 301-304
123. Schols D, Pauwels R, Desmyter J, de CE (1990) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-Cells persistently infected with HIV-1. Virology 175: 556-561
124. Schuitz T, Reeves J, Hoad J, Tailor C, Stephens P, Glements G, Ortlepp S, Page K, Moore J, Weiss R (1993) Effects of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage AIDS Res Hum Retroviruses 9: 159-166
125. Seddiki N, Ramdani A, Saffar L, Portoukalian J, Gluckman JC, Gattegno L (1994) A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus Biochim Biophys Acta Mol Basis Dis 1225 289-296
126. ShapiraNahor O, Golding H, Vujcic LK, RestoRuiz S, Fields RL, Robey FA (1990) CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection. Cell Immunol 128 101-117
127. Simon J, Schockmel G, Illei P, James W (1994) A rodent cell line permissive for entry and reverse transcription of HIV-1 has a pre-integration block to productive infection. J Gen Virol 75 2615-2623
128. Simon JH, Somoza C, Schockmel GA, Collin M, Davis SJ, Williams AF, James W (1993) A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J Exp Med 177 949-954
129. Simon JHM, James W (1994) Heterokaryons formed between a rat myeloma and a mouse fibroblast are permissive for entry of HIV-1 AIDS Res Hum Retroviruses 70 7609-7677
130. Smith DH, Byrn RA, Marsters SA, Gregory T, Groopman JE, Capon DJ (1987) Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 238 1704-1707
131. Spear PG, Shieh MT, Herold BC, WuDunn D, Koshy TI (1992) Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus Adv Exp Med Biol 313 341-353
132. Spouge JL (1994) Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies J Virol 68: 1782-1789
133. Stefano KA, Collman R, Kolson D, Hoxie J, Nathanson N, GonzalezScarano F (1993) Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx74, suggests that cellular accessory molecules are required for HIV-1 entry. J Virol 67: 6707-6715
134. Sutor GC, Dreikhausen U, Vahning U, Jurkiewicz E, Hunsmann, G, Lundin K, Schedel I (1992) Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4: potential for idiotype immunization against HIV. J Immunol 149: 1452-1461
135. Syu W-J, Huang J-H, Essex M, Lee T-H (1990) The N-terminal region of the human immunodeficiency virus envelope glycoprotein contains potential binding sites for CD4 Proc Natl Acad Sci USA 87. 3695-3699
136. Takeda A, Tuazon CU, Ennis FA (1988) Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry Science 242 580-583
137. Tanabe TA, Tochikura TS, Blakeslee JJ, Olsen RG, Mathes LE (1992) Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro Antiviral Res 19: 161-172
138. Teshima G, Porter J, Yim k, Ling V, Guzzetta A (1991) Deamidatron of soluble CD4 at asparagine-52 results in reduced binding capacity for the HIV-1 envelope glycoprotein gp120, Biochemistry 30: 3916-3922
139. Thali M, Olshevsky, U, Furman C, Gabuzda D, Li J, Sodroski J (1991) Effects in changes of gp120-CD4 binding affinity on human immunodeficiency type 1 envelope glycoprotein function and soluble CD4 sensitivity J Virol 88: 5007-5012
140. Thieblemont N, HaeffnerCavaillon N, Ledur A, LageStehr J, ZieglerHeitbrock H, Kazatchkine MD (1993) CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4, Clin Exp Immunol 92 106-113
141. Traunecker A, Luke W, Karjalainen K (1988) Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 331: 84-86
142. Truneh A, Buck D, Cassatt DR, Juszczak R, Kassis S, Ryu SE, Healey D, Sweet R, Sattentau Q (1991) A region tn domain 1 of CD4 distinct form the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem 266: 5942-5948
143. Tsui P, Sweet RW, Sathe G, Rosenberg M (1992) An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J Biol Chem 267: 9361-9367
144. Valentin A, Lundin K, Patarroyo M, Asjo B (1990) The leukocyte adhesion glycoprotein CD18 participates in HIV-1-induced syncytia formation in monocytoid and T cells. J Immunol 144 934-937
145. van den Berg L, Sadiq SA, Lederman S, Latov N (1992) The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein J Neurosci Res 33: 513-518
146. VermotDesroches C, Rigal D, Escaich S, Bernaud J, Pichoud C, Lamelin JP, Trepo C (1991) Functional epttope analysis of the human CD11a/CD18 molecule (LFA-1, lymphocyte function-associated antigen 1) involved in HIV-1-induced syncytium formation. Scand Immunol 34. 461-470
147. Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains (see comments). Nature 348: 411-418
148. Weiner DB, Huebner K, Williams WV, Greene MI (1991) Human genes other than CD4 facilitate HIV-1 infection of murine cells. Pathobiology 59 361-371
149. Weiss R (1993) Cellular receptors and viral glycoproteins involved in retrovirus entry. In: Levy J (ed) The retroviridae, vol 2. Plenum, New York, pp 1-108
150. Willey RL, Martin MA, Peden K (1994) Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. J Virol 68: 1029-1039
151. Wyatt R, Sullivan N, Thali M, Repke H, Ho D, Robinson J, Posner M, Sodroski J (1993) Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions 67 4557-4565
152. Zeira M, Byrn RA, Groopman JE (1990) Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody AIDS Res Hum Retroviruses 6: 629-639